David Joseph Topper

Insider Reports History

Location
New York, NY
Signature
/s/ Masaru Matsuda, Attorney-on-Fact for David Topper
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Joseph Topper:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 182,774 $2,888,176 $15.80 02 Apr 2025 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 89,000 28 Feb 2025 Direct
Frazier Lifesciences Acquisition Corp Chief Financial Officer, Director Class B Ordinary Shares 0 22 Nov 2022 Direct

Insider Reports Filed by David Joseph Topper

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARQT Arcutis Biotherapeutics, Inc. 02 Apr 2025 1 -$151,698 4 Chief Financial Officer 03 Apr 2025, 16:21
ARQT Arcutis Biotherapeutics, Inc. 28 Feb 2025 2 $0 4 Chief Financial Officer 04 Mar 2025, 19:43
ARQT Arcutis Biotherapeutics, Inc. 21 Sep 2024 2 -$110,264 4 Chief Financial Officer 25 Sep 2024, 21:42
ARQT Arcutis Biotherapeutics, Inc. 10 Apr 2024 2 $0 4 Chief Financial Officer 11 Apr 2024, 20:32
ARQT Arcutis Biotherapeutics, Inc. 10 Apr 2024 0 $0 3 Chief Financial Officer 11 Apr 2024, 20:30
/report/000089924322036936-topper-david-joseph-2022-11-22 Frazier Lifesciences Acquisition Corp 22 Nov 2022 1 $0 4 Chief Financial Officer, Director 23 Nov 2022, 15:31